NO20081480L - Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma - Google Patents

Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma

Info

Publication number
NO20081480L
NO20081480L NO20081480A NO20081480A NO20081480L NO 20081480 L NO20081480 L NO 20081480L NO 20081480 A NO20081480 A NO 20081480A NO 20081480 A NO20081480 A NO 20081480A NO 20081480 L NO20081480 L NO 20081480L
Authority
NO
Norway
Prior art keywords
copd
asthma
compounds
treatment
combination
Prior art date
Application number
NO20081480A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Eriksson
Johan Hansson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37771856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081480(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20081480L publication Critical patent/NO20081480L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20081480A 2005-08-26 2008-03-26 Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma NO20081480L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0501896 2005-08-26
SE0601220 2006-06-01
PCT/SE2006/000970 WO2007024182A1 (fr) 2005-08-26 2006-08-24 Combinaison de composés pouvant être employée dans le traitement de maladies respiratoires, en particulier de broncho-pneumopathie chronique obstructive (bpco) et d'asthme

Publications (1)

Publication Number Publication Date
NO20081480L true NO20081480L (no) 2008-05-16

Family

ID=37771856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081480A NO20081480L (no) 2005-08-26 2008-03-26 Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma

Country Status (19)

Country Link
US (1) US20090215732A1 (fr)
EP (1) EP1922074B1 (fr)
JP (1) JP2009506028A (fr)
KR (1) KR20080038361A (fr)
AR (1) AR055614A1 (fr)
AT (1) ATE457731T1 (fr)
AU (2) AU2006282121B2 (fr)
BR (1) BRPI0615110A2 (fr)
CA (1) CA2620847A1 (fr)
DE (1) DE602006012332D1 (fr)
EC (1) ECSP088287A (fr)
HK (1) HK1116095A1 (fr)
IL (2) IL189195A0 (fr)
MX (1) MX2008002321A (fr)
NO (1) NO20081480L (fr)
RU (1) RU2414222C2 (fr)
TW (1) TW200744612A (fr)
UY (1) UY29760A1 (fr)
WO (1) WO2007024182A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008103126A1 (fr) * 2007-02-23 2008-08-28 Astrazeneca Ab Nouvelle combinaison de composés utilisés dans le traitement des maladies des voies aériennes, en particulier la bronchopneumopathie chronique obstructive (copd) et l'asthme
US20110136843A1 (en) * 2007-02-23 2011-06-09 Tomas Eriksson Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
WO2009142588A1 (fr) * 2008-05-20 2009-11-26 Astrazeneca Ab Combinaison de: (a) un antagoniste du récepteur 1 de la chimiokine (ccr1) et (b) un modulateur des récepteurs des glucocorticoïdes
GB0811099D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination 376
BR112014008114B1 (pt) 2011-10-11 2022-07-26 Chiesi Farmaceutici S.P.A. Micropartículas cristalinas, formulação farmacêutica, inalador dosimetrado pressurizado, formulação farmacêutica, processo para preparar microparticulas cristalinas e uso de micropartículas cristalinas
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
CA3185526A1 (fr) * 2020-07-28 2022-02-03 Laura L. Eggink Methode de traitement de pathologies inflammatoires entrainees par neutrophiles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
SE378109B (fr) * 1972-05-19 1975-08-18 Bofors Ab
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
WO2001098270A2 (fr) * 2000-06-21 2001-12-27 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines utiles comme modulateurs de l'activite du recepteur de chimiokine
GB0029562D0 (en) * 2000-12-04 2001-01-17 Novartis Ag Organic compounds
SI1383786T1 (sl) * 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
US20030229058A1 (en) * 2001-11-13 2003-12-11 Moran Edmund J. Aryl aniline beta2 adrenergic receptor agonists
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
GB0207436D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
JP2007523871A (ja) * 2003-07-15 2007-08-23 メルク　エンド　カムパニー　インコーポレーテッド ケモカイン受容体活性の７および８員複素環式シクロペンチルベンジルアミドモジュレーター

Also Published As

Publication number Publication date
US20090215732A1 (en) 2009-08-27
EP1922074B1 (fr) 2010-02-17
RU2008108175A (ru) 2009-10-10
AU2009202925B2 (en) 2011-04-28
IL189195A0 (en) 2008-08-07
ATE457731T1 (de) 2010-03-15
CA2620847A1 (fr) 2007-03-01
KR20080038361A (ko) 2008-05-06
WO2007024182A1 (fr) 2007-03-01
AR055614A1 (es) 2007-08-29
JP2009506028A (ja) 2009-02-12
AU2006282121B2 (en) 2009-12-24
AU2009202925A1 (en) 2009-08-06
HK1116095A1 (en) 2008-12-19
MX2008002321A (es) 2008-03-14
RU2414222C2 (ru) 2011-03-20
TW200744612A (en) 2007-12-16
BRPI0615110A2 (pt) 2011-05-03
EP1922074A1 (fr) 2008-05-21
UY29760A1 (es) 2007-03-30
DE602006012332D1 (de) 2010-04-01
AU2006282121A1 (en) 2007-03-01
IL199022A0 (en) 2010-02-17
ECSP088287A (es) 2008-04-28

Similar Documents

Publication Publication Date Title
NO20082000L (no) Pyrimidinamidforbindelser som PGDS-inhibitorer
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
UY29506A1 (es) Nuevas formas cristalinas de bromuro de tiotropio
WO2004045618A3 (fr) Nouveaux medicaments destines au traitement de la bronchopneumopathie chronique obstructive
MX2009009443A (es) Compuestos de pirimidina hidrazida como inhibidores de pgds.
WO2006117300A3 (fr) Formes cristallines de bromure de tiotropium
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
CL2008001898A1 (es) Compuestos derivados de pirazinona, inhibidores de p38; proceso de preparacion de estos; composicion farmaceutica que los comprende; combinacion farmaceutica que los comprende; uso para tratar enferemedades pulmonares obstructivas cronicas y asma.
EP1865967A4 (fr) Composes, compositions et methodes de traitement d'infections virales et autres troubles medicaux
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
ECSP066543A (es) Nuevo anhidrato cristalino con accion anticolinergica
NO20084328L (no) Nye forbindelser
MX2009001534A (es) Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
CL2007002274A1 (es) Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras.
NO20074084L (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
NO341676B1 (no) Tetrahydro-pyrimidoazepiner som modulatorer av TRPVI
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
NO20081483L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
CL2008000973A1 (es) Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma.
NO20090193L (no) Substituerte heterocykliske etere og anvendelse derav i CNS forstyrrelser
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
NO20083695L (no) Meridamycin analoger for behandlingen av neurodegenererende sykdommer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application